References
- Bessey O. A., Lowry O. H., Brock M. J. A method for the rapid determination of alkaline phosphatase with five cubic millimeters of serum. J. biol. Chem. 1946; 164: 321
- Carbone J. V., Grodsky G. M., Hjelte V. Effect of hepatic function on circulating levels of sulfobromophtalein and its metabolites. J. din. Invest. 1959; 38: 1989
- Dufault C., Tremblay G., Nowaczynski W., Genest J. Influence of dextro-thyroxine and androsterone on blood clotting factors and serum cholesterol in patients with atherosclerosis. Canad. med. Ass. J. 1961; 85: 1025
- Fauvert R. E. The concept of hepatic clearance. Gastroenterology 1959; 37: 603
- Furman K. H., Howard R. P., Alaupovic P. Reduction in serum lipid levels during oral administration of C-17 alkylated steroids, methyltestosterone and methylandrostanopyrazole, to hyperlipemic subjects. J. Lab. clin. Med. 1962; 60: 876
- Furman R. H., Howard R. P. Effects of androsterone and triiodothyronine on serum lipids and lipoproteins, nitrogen balance and related metabolic phenomena in subjects with normal and decreased thyroid function, with hyperglyceridemia and/or hypercholesteremia. Metabolism 1962; 11: 76
- Liddle G. W., Burke H. A. Anabolic steroids in clinical medicine. Helv. med. Acta 1960; 27: 504
- Marquardt G. H., Fisher C. I., Levy P., Dowben R. M. Effect of anabolic steroids on liver function tests and creatine excretion. J. Amer. med. Ass. 1961; 175: 115
- Mertz D. P. Über die Wirkung von Prednison und Testosteron auf die Aktivität der alkalischen Serumphosphatase. Z. klin. Med. 1958; 155: 329
- Oliver M. F. Reduction of serum lipid and uric-acid levels by an orally active androsterone. Lancet 1962; i: 1321
- Roberts S. D., Hayes D., Pantridge J. F., Suzman M. M., Bersohn I. Effect of Atromid and ethyl chlorophenoxyisobutyrate on anticoagulant requirements. Ibid. 1963; 143
- Owren P. A., Aas K. The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin. Scand. J. clin. Lab. Invest. 1951; 3: 209
- Sherlock S. Jaundice. Brit. med. J. 1962; i: 1359
- Soler-Argilaga C., Sans-Sabrafen J., Vidal M. T., Gras J., Bacardi R., Llombart D. Alteraciones hepáticas por la metandrostenolona. Rev. clin. esp. 1962; 87: 212
- Thorp J. M. Experimental evaluation of an orally active combination of androsterone with ethyl chlorophenoxyisobutyrate. Lancet 1962; i: 1323
- Werner M., Hitz A., Gloor F., Thölen H. Die Wirkung von hlethandrostenolon auf die meschliche Leber. Klin. Wschr. 1961; 39: 1006
- Wernze H. Klinische Untersucliungen zur Frage der Leberschadigung durch neuere androgene und anabole Steroide. Dtsch. med. Wschr. 1960; 85: 2237
- Wildhirt E. Fermentstoffwechsel der Leber. Wien. klin. Wschr. 1962; 74: 162
- Wynn V., Landon J., Kawerau E. Studies of hepatic function during methandienone therapy. Lancet 1961; i: 69